Sir H.N. Reliance Foundation Hospital Hosts Breast Cancer Awareness Conference Focused on Innovation and Survivorship

Sir H.N. Reliance Foundation Hospital convened a high-impact Breast Cancer Awareness Meeting, bringing together medical experts, survivors, and thought leaders to advance dialogue on innovation, treatment, and survivorship in breast cancer care. The conference served as a platform for sharing cutting-edge research, clinical insights, and patient-centric approaches that are reshaping oncology in India.

The event was graced by Bollywood actor and breast cancer survivor Hina Khan, whose presence added emotional depth and public resonance to the proceedings. In a heartfelt address, Khan shared her personal journey through diagnosis, treatment, and recovery, emphasizing the importance of early detection, mental resilience, and community support. Her story underscored the silent nature of breast cancer and the need for widespread awareness campaigns that empower women to seek timely care.

Leading the medical discourse were Dr. Tarang Gianchandani, Group CEO – Healthcare Initiatives & CEO of Sir H.N. Reliance Foundation Hospital; Dr. Sewanti Limaye, Director – Medical & Precision Oncology; and Dr. Vijay Haribhakti, Chair – Oncosciences. Together with senior oncologists and specialists, they presented updates on systemic therapies, precision medicine, and emerging diagnostic tools that are improving outcomes for breast cancer patients across subtypes.

One of the key themes of the conference was innovation in breast cancer diagnostics. Experts discussed the role of AI-powered imaging, liquid biopsies, and genomic profiling in enabling earlier and more accurate detection. These technologies are particularly impactful in identifying aggressive subtypes and tailoring treatment plans to individual patient profiles.

The session on breast cancer subtypes explored the biological diversity of the disease, from hormone receptor-positive to triple-negative and HER2-positive cancers. Oncologists emphasized the importance of subtype-specific therapies, including targeted drugs, immunotherapy, and combination regimens that are now part of standard care protocols.

Another highlight was the panel on patient advocacy and survivorship, which addressed the psychosocial dimensions of breast cancer. Discussions focused on post-treatment rehabilitation, mental health support, and the role of caregivers. Survivors and advocates called for more inclusive policies, insurance reforms, and community-based programs that ensure continuity of care beyond hospital walls.

Dr. Sewanti Limaye noted that “breast cancer treatment is no longer one-size-fits-all. Precision oncology is allowing us to personalize care, reduce toxicity, and improve survival rates. But we must also invest in awareness and access, especially in underserved regions.”

Dr. Vijay Haribhakti added, “Our goal is not just to treat cancer, but to restore quality of life. That means integrating nutrition, physiotherapy, counseling, and long-term monitoring into every patient’s journey.”

The conference also showcased collaborative research initiatives between Sir H.N. Reliance Foundation Hospital and global institutions, aimed at developing affordable therapies and scalable screening models for India’s diverse population. These partnerships reflect the hospital’s commitment to clinical excellence and social responsibility.

As breast cancer continues to be one of the most prevalent cancers among Indian women, events like this play a crucial role in bridging gaps between science, society, and survivors. They foster a culture of empathy, evidence-based care, and collective action.

The Breast Cancer Awareness Meeting concluded with a renewed call to action: to destigmatize cancer, democratize access to care, and celebrate the strength of survivors. With voices like Hina Khan and the expertise of India’s top oncologists, the message was clear—breast cancer is beatable, and every woman deserves the chance to fight it with dignity and support.